Pharmacological, Biochemical and Immunological Studies on Protective Effect of Mangiferin in 6-Hydroxydopamine (6-OHDA)-Induced Parkinson's Disease in Rats.

Prafulla Chandra TiwariManju J ChaudharyRishi PalShipra KartikRajendra Nath

Published in: Annals of neurosciences (2021)

Current treatment of Parkinson's disease does not target progression of Parkinson's disease. Results of this study suggest that mangiferin has protective effect in hemi-Parkinsonian rats. Therefore, the combination therapy of mangiferin and levodopa can be helpful in management of Parkinson's disease.

Keyphrases

combination therapy
parkinson disease
stress induced